A woman from Chester Springs, Pennsylvania, is one of the first patients in the country to receive a new FDA-approved ...

The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 600.18% and ...

In the 1990s, Eli Lilly researched a molecule called xanomeline for Alzheimer’s disease, and found it had potent ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...

Shares of Eli Lilly & Co. LLY slid 1.65% to $909.32 Thursday, on what proved to be an all-around favorable trading session ...

While providing compounded versions of patented drugs is legal when the FDA-approved versions are in shortage, manufacturers ...

Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public ...

An investigation, published in the journal The BMJ, found that the newly U.S. Food & Drug Administration-approved donanemab is linked ...

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its ...

A study from tirzepatide's manufacturer found that the GLP-1 drug could significantly improve heart failure symptoms.